Cytokines and tuberculosis

The evolution of Mycobacterium tuberculosis as an intracellular pathogen has led to a complex relationship between it and its host, the human mononuclear phagocyte. The products of M. tuberculosis–specific T lymphocytes are essential for macrophage activation for intracellular mycobacterial killing. However, some cytokines, including products of both lymphocytes and phagocytic cells, may contribute to enhanced mycobacterial survival and replication. In human immunodeficiency virus‐associated tuberculosis, cytokine products may mediate enhanced susceptibility to tuberculosis as well as accelerated progression to AIDS. Better understanding of these interactions will allow the development of increasingly specific immune‐based interventions for prevention and treatment of tuberculosis. J. Leukoc. Biol. 55: 676–681; 1994.

[1]  I. Orme,et al.  Disseminated tuberculosis in interferon gamma gene-disrupted mice , 1993, The Journal of experimental medicine.

[2]  J. Flynn,et al.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.

[3]  G. Kaplan,et al.  The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum. , 1993, The Journal of infectious diseases.

[4]  L. Bermudez,et al.  Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice , 1993, Infection and immunity.

[5]  J. Castrillo,et al.  Visceral leishmaniasis in patients with AIDS: report of three cases treated with pentavalent antimony and interferon-gamma. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  J. Abrams,et al.  Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. , 1993, Journal of immunology.

[7]  J. Abrams,et al.  Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. , 1993, Journal of immunology.

[8]  T. Hada,et al.  Local production and localization of transforming growth factor‐beta in tuberculous pleurisy , 1993, Clinical and experimental immunology.

[9]  P. Zabel,et al.  Inhibition of endogenous TNF formation by pentoxifylline. , 1993, Immunobiology.

[10]  H. Shiratsuchi,et al.  Colonial morphotype as a determinant of cytokine expression by human monocytes infected with Mycobacterium avium. , 1993, Journal of immunology.

[11]  H. Schuitemaker,et al.  T-cell dysfunction in HIV infection: anergy due to defective antigen-presenting cell function? , 1993, Immunology today.

[12]  A. Bradley,et al.  Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. , 1993, Science.

[13]  C. Hendrix,et al.  Early markers of HIV infection and subclinical disease progression. , 1993, Vaccine.

[14]  L. Bermudez.  Production of transforming growth factor-beta by Mycobacterium avium-infected human macrophages is associated with unresponsiveness to IFN-gamma. , 1993, Journal of immunology.

[15]  J. Blackwell,et al.  Macrophage activation: lipoarabinomannan from avirulent and virulent strains of Mycobacterium tuberculosis differentially induces the early genes c-fos, KC, JE, and tumor necrosis factor-alpha. , 1993, Journal of immunology.

[16]  R. Paranjape,et al.  Identification by two-dimensional gel electrophoresis of a 58-kilodalton tumor necrosis factor-inducing protein of Mycobacterium tuberculosis , 1993, Infection and immunity.

[17]  J. Abrams,et al.  Patterns of cytokine production by mycobacterium-reactive human T-cell clones , 1993, Infection and immunity.

[18]  P. Selwyn,et al.  Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. , 1992, The New England journal of medicine.

[19]  Nalin Rastogi,et al.  Intracellular growth of Mycobacterium avium in human macrophages is linked to the increased synthesis of prostaglandin E2 and inhibition of the phagosome-lysosome fusions. , 1992, FEMS microbiology immunology.

[20]  H. Bernheimer,et al.  Specific inhibition of mRNA accumulation for lymphokines in human T cell line Jurkat by mycobacterial lipoarabinomannan antigen , 1992, Clinical and experimental immunology.

[21]  Alan D. Roberts,et al.  Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor , 1992, Infection and immunity.

[22]  S. Chensue,et al.  Immunohistochemical demonstration of interleukin-1 receptor antagonist protein and interleukin-1 in human lymphoid tissue and granulomas. , 1992, The American journal of pathology.

[23]  G. Schoolnik,et al.  An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. , 1992, The New England journal of medicine.

[24]  Z. Fan,et al.  Augmentation of cellular immune function during the early phase of zidovudine treatment of AIDS patients. , 1991, The Journal of infectious diseases.

[25]  H. Shiratsuchi,et al.  Preservation of monocyte effector functions against Mycobacterium avium-M. intracellulare in patients with AIDS , 1991, Infection and immunity.

[26]  Elizabeth,et al.  Selection of a human T helper type 1-like T cell subset by mycobacteria , 1991, The Journal of experimental medicine.

[27]  J. Ellner.  Regulation of the human cellular immune response to Mycobacterium tuberculosis. The mechanism of selective depression of the response to PPD. , 1991, Bulletin of the International Union against Tuberculosis and Lung Disease.

[28]  E. Gregg,et al.  Recombinant interleukin-6 increases the intracellular and extracellular growth of Mycobacterium avium. , 1991, Canadian journal of microbiology.

[29]  S. Shiboski,et al.  Immune activation markers and AIDS prognosis , 1991, AIDS.

[30]  H. Saka,et al.  Cytokine content in pleural effusion. Comparison between tuberculous and carcinomatous pleurisy. , 1991, Chest.

[31]  P. Brennan,et al.  Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages , 1991, Infection and immunity.

[32]  H. Shiratsuchi,et al.  Bidirectional effects of cytokines on the growth of Mycobacterium avium within human monocytes. , 1991, Journal of immunology.

[33]  M. Denis.  Journal of Leukocyte Biology 49:380-387 (1991) Tumor Necrosis Factor and Granulocyte Macrophage- Colony Stimulating Factor Stimulate Human Macrophages to Restrict Growth of Virulent Mycobacterium avium and to Kill Avirulent M. avium: Killing Effector Mech , 2022 .

[34]  V. Kindler,et al.  The beneficial effects of localized tumor necrosis factor production in BCG infection. , 1991, Behring Institute Mitteilungen.

[35]  R. Chaisson,et al.  Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. , 1991, The New England journal of medicine.

[36]  J. Ellner.  Tuberculosis in the time of AIDS. The facts and the message. , 1990, Chest.

[37]  S. Kishimoto,et al.  Production of tumor necrosis factor alpha by monocytes from patients with pulmonary tuberculosis , 1990, Infection and immunity.

[38]  E. Gregg,et al.  Recombinant tumour necrosis factor-alpha decreases whereas recombinant interleukin-6 increases growth of a virulent strain of Mycobacterium avium in human macrophages. , 1990, Immunology.

[39]  H. Young,et al.  Expression of human immunodeficiency virus long terminal repeat in the human promonocyte cell line U937: effect of endotoxin and cytokines. , 1990, Cellular immunology.

[40]  L. Sibley,et al.  Gamma interferon in experimental leprosy. , 1990, Diagnostic microbiology and infectious disease.

[41]  B. Milleron,et al.  In vitro production of tumour necrosis factor and prostaglandin E2 by peripheral blood mononuclear cells from tuberculosis patients , 1990, Clinical and experimental immunology.

[42]  L. Bermudez,et al.  Recombinant Granulocyte–Macrophage Colony‐Stimulating Factor Activates Human Macrophages to Inhibit Growth or Kill Mycobacterium avium Complex , 1990, Journal of leukocyte biology.

[43]  Z. Toossi,et al.  Expression of functional interleukin 2 receptors by peripheral blood monocytes from patients with active pulmonary tuberculosis. , 1990, The Journal of clinical investigation.

[44]  J. Ellner,et al.  Induction of interleukin 1 and tumor necrosis factor by mycobacterial proteins: the monocyte western blot. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. Martin,et al.  Replication of HIV-1 in primary monocyte cultures. , 1990, Virology.

[46]  L. Sibley,et al.  Inhibition of interferon‐gamma‐mediated activation in mouse macrophages treated with lipoarabinomannan , 1990, Clinical and experimental immunology.

[47]  A. J. Crowle,et al.  Relative permissiveness of macrophages from black and white people for virulent tubercle bacilli , 1990, Infection and immunity.

[48]  R. Luzzati,et al.  NOSOCOMIAL EPIDEMIC OF ACTIVE TUBERCULOSIS AMONG HIV-INFECTED PATIENTS , 1989, The Lancet.

[49]  G. Rook,et al.  Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages. , 1989, Clinical and experimental immunology.

[50]  V. Kindler,et al.  The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection , 1989, Cell.

[51]  J. Ellner,et al.  Expression of tumor necrosis factor in vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens , 1988, Infection and immunity.

[52]  L. Bermudez,et al.  Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. , 1988, Journal of immunology.

[53]  L. Sibley,et al.  Mycobacterial lipoarabinomannan inhibits gamma interferon-mediated activation of macrophages , 1988, Infection and immunity.

[54]  H. Murray.  Interferon-gamma, the activated macrophage, and host defense against microbial challenge. , 1988, Annals of internal medicine.

[55]  J. Justement,et al.  Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. , 1988, Journal of immunology.

[56]  G. Rook,et al.  The role of gamma-interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis. , 1987, Immunology.

[57]  B. Balbi,et al.  Tuberculous pleural effusions. Evidence for selective presence of PPD-specific T-lymphocytes at site of inflammation in the early phase of the infection. , 1987, The American review of respiratory disease.

[58]  G. Kaplan,et al.  Cellular responses to the intradermal injection of recombinant human gamma-interferon in lepromatous leprosy patients. , 1987, The American journal of pathology.

[59]  S. Kaufmann,et al.  Mycobacterial growth inhibition by interferon-gamma-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis. , 1987, Journal of immunology.

[60]  A. Rivarola.  Increased interleukin-1 production and monocyte suppressor cell activity associated with human tuberculosis. , 1987, The American review of respiratory disease.

[61]  M. Kaplan,et al.  In vitro and in vivo activation of human mononuclear phagocytes by interferon-gamma. Studies with normal and AIDS monocytes. , 1987, Journal of immunology.

[62]  A. Pinching,et al.  Microbicidal activity of monocyte derived macrophages in AIDS and related disorders. , 1987, Clinical and experimental immunology.

[63]  M. Horwitz,et al.  Interferon-gamma-activated human monocytes inhibit the intracellular multiplication of Legionella pneumophila. , 1986, Journal of immunology.

[64]  Z. Toossi,et al.  Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis , 1986, The Journal of experimental medicine.

[65]  H. Fujiwara,et al.  Frequency of tuberculin-reactive T-lymphocytes in pleural fluid and blood from patients with tuberculous pleurisy. , 1986, Chest.

[66]  H. Fujiwara,et al.  Direct stimulation of monocyte release of interleukin 1 by mycobacterial protein antigens. , 1986, Journal of immunology.

[67]  A. J. Crowle,et al.  Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria , 1985, Infection and immunity.

[68]  C. Nathan,et al.  Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma. , 1985, Journal of immunology.

[69]  J. Robinson,et al.  Deficient immune interferon production in tuberculosis. , 1985, Clinical and experimental immunology.

[70]  B. Champion,et al.  I-A restricted activation by T cell lines of anti-tuberculosis activity in murine macrophages. , 1985, Clinical and experimental immunology.

[71]  P. Gros,et al.  Phenotypic expression of genetically-controlled natural resistance to Mycobacterium bovis (BCG). , 1984, Journal of immunology.

[72]  K. Shimokata,et al.  Local cellular immunity in tuberculous pleurisy. , 1982, The American review of respiratory disease.

[73]  H. Fujiwara,et al.  In vitro tuberculin reactivity of lymphocytes from patients with tuberculous pleurisy , 1982, Infection and immunity.

[74]  M. Meltzer,et al.  Intracellular replication and lymphokine-induced destruction of Leishmania tropica in C3H/HeN mouse macrophages. , 1981, Journal of immunology.

[75]  J. Ellner,et al.  Suppression of lymphocyte responses by tuberculous plasma and mycobacterial arabinogalactan. Monocyte dependence and indomethacin reversibility. , 1981, The Journal of clinical investigation.

[76]  M. Oxtoby,et al.  The immune spectrum in patients with pulmonary tuberculosis. , 1981, The American review of respiratory disease.

[77]  D. Nash,et al.  Anergy in Active Pulmonary Tuberculosis , 1980 .

[78]  J. Ellner.  Pleural fluid and peripheral blood lymphocyte function in tuberculosis. , 1978, Annals of internal medicine.

[79]  J. J. Waring,et al.  Primary serofibrinous pleural effusion in military personnel. , 1955, American review of tuberculosis.

[80]  M. Vjecha,et al.  Influence of tuberculosis on human immunodeficiency virus (HIV-1): enhanced cytokine expression and elevated beta 2-microglobulin in HIV-1-associated tuberculosis. , 1993, The Journal of infectious diseases.

[81]  Management of persons exposed to multidrug-resistant tuberculosis. , 1992, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[82]  M. Piccinni,et al.  In vitro Infection with hiv of antigen-specific t cell clones derived from hiv-seronegative individuals. effects on cytokine production and helper function , 1991, La Ricerca in clinica e in laboratorio.

[83]  G. Nabel,et al.  Induction of NF-kappa B during monocyte differentiation is associated with activation of HIV-gene expression. , 1991, Research in virology.

[84]  R. Coffman,et al.  CD4+ T-cell subsets: regulation of differentiation and function. , 1991, Research in immunology.

[85]  R. Coffman,et al.  Lymphokine control of in vivo immunoglobulin isotype selection. , 1990, Annual review of immunology.

[86]  M Denis,et al.  Cytokine modulation of Mycobacterium tuberculosis growth in human macrophages. , 1990, International journal of immunopharmacology.

[87]  R. Badaró,et al.  Serum interferon activity of patients with leishmaniasis. , 1989, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[88]  R. Coffman,et al.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.

[89]  E. Skamene,et al.  Genetic basis of host resistance and susceptibility to intracellular pathogens. , 1988, Advances in experimental medicine and biology.

[90]  G. Rook,et al.  Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. , 1986, Immunology.

[91]  H. Fujiwara,et al.  Increased interleukin-1 production and monocyte suppressor cell activity associated with human tuberculosis. , 1986, The American review of respiratory disease.

[92]  D. Tweardy,et al.  Association of altered dynamics of monocyte surface expression of human leukocyte antigen DR with immunosuppression in tuberculosis. , 1984, The Journal of infectious diseases.

[93]  D. Nash,et al.  Anergy in active pulmonary tuberculosis. A comparison between positive and negative reactors and an evaluation of 5 TU and 250 TU skin test doses. , 1980, Chest.